Min‐Xia Su

Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells

Xiaoming Jiang, Yulian Xu, Mu‐Yang Huang et al. · Acta Pharmacologica Sinica · 2017 · 76 citations · Full text

Tumor Biology, Medicine, Cell Death +10

Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells

Zhenghai Tang, Wenxiang Cao, Min‐Xia Su et al. · Toxicology and Applied Pharmacology · 2017 · 72 citations

Cell Autophagy, Mitophagy, Medicine +10

Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells

Luo‐Wei Yuan, Xiaoming Jiang, Yulian Xu et al. · Phytomedicine · 2020 · 44 citations

Oncogenic Agent, Medicine, Immunology +11

Increased Expression of IRE1α Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells

Zhenghai Tang, Min‐Xia Su, Xia Guo et al. · Anti-Cancer Agents in Medicinal Chemistry · 2017 · 35 citations

Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells

Lele Zhang, Zheling Feng, Min‐Xia Su et al. · European Journal of Pharmacology · 2018 · 33 citations

Oncology, Cell Regulation, Medicine +9